Putnam Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Putnam Investments’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-86,979	Closed	-$10.5M	–	1233
2023 Q1	$10.5M	Sell	86,979 -1,361	-2%	-$157K	0.02%	302
2022 Q4	$10.1M	Buy	88,340 +13,464	+18%	+$1.48M	0.02%	279
2022 Q3	$7.66M	Sell	74,876 -8,530	-10%	-$902K	0.01%	339
2022 Q2	$8.47M	Buy	83,406 +11,325	+16%	+$1.24M	0.02%	330
2022 Q1	$8.39M	Buy	72,081 +1,030	+1%	+$119K	0.01%	380
2021 Q4	$8.08M	Buy	+71,051	New	+$8.1M	0.01%	425
2021 Q1	–	Sell	-55,818	Closed	-$6.1M	–	857
2020 Q4	$6.1M	Sell	55,818 -22,003	-28%	-$2.38M	0.01%	467
2020 Q3	$8.66M	Buy	77,821 +11,845	+18%	+$1.33M	0.02%	362
2020 Q2	$6.92M	Buy	+65,976	New	+$7.07M	0.01%	406

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Putnam Investments's BSX.PRA Position: Q2 2023 in Review

Putnam Investments sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 86,979 shares — an estimated $10.5M sold.

Putnam Investments first reported a position in BSX.PRA in Q2 2020 and held it in 9 quarters. The position peaked at $10.5M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Putnam Investments reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Putnam Investments sold 86,979 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $10.5M.
Putnam Investments first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 9 quarters.
Putnam Investments's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $10.5M in Q1 2023.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Putnam Investments's 13F filing for Q2 2023, filed 14 Aug 2023.